A Timeline of the CRISPR/Cas System
Michelle Dotzert, PhD | November 11, 2020
From discovery and development to clinical applications
Articles by Michelle Dotzert, PhD
Utility of Electronic Health Records in Randomized Controlled Trials
Michelle Dotzert, PhD | November 1, 2020
Beyond interventions, EHRS may be used for recruitment and outcome assessment
CHIP Screening: Potential Value in the Clinical Setting
Michelle Dotzert, PhD | October 15, 2020
Screening for blood cell mutations can identify those at greater risk for hematologic cancers and cardiovascular disease
Why Greater Diversity is Needed in Genomic Research
Michelle Dotzert, PhD | September 4, 2020
Including participants of diverse ancestries in genome-wide association studies improves disease risk prediction, diagnosis, and development of treatments
Analytical Challenges in Doping Detection
Michelle Dotzert, PhD | September 2, 2020
As new compounds and masking agents continue to emerge, analytical methods must evolve to enable their detection
How to Diagnose Mosquito-Borne Diseases
Michelle Dotzert, PhD | May 12, 2020
Mosquito-borne diseases are transmitted when a mosquito ingests viruses, parasites, or bacteria from a host and injects them into another individual
Cardiac Biomarkers for Diagnosis, Prognosis, and Therapy Guidance
Michelle Dotzert, PhD | April 16, 2020
Reduction of circulating cardiac biomarkers is often associated with improved prognosis, making them potentially useful in therapy guidance
Endometriosis: Theories of Pathogenesis
Michelle Dotzert, PhD | April 7, 2020
Often referred to as an "invisible illness," endometriosis remains poorly understood
A Timeline of Pandemics
Michelle Dotzert, PhD | March 18, 2020
How pathogens have shaped our history
Trends in Clinical Microbiology Diagnostic Methods
Michelle Dotzert, PhD | November 30, 2019
Emerging methods focus in speed, accuracy, and cost effectiveness